NCT01308762 2012-12-06A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer PatientsImmodulon Therapeutics LtdPhase 1 Completed19 enrolled 10 charts